Scribd Logo
Upload

Welcome to Scribd!

  • 1K views

    Drug Study Apidra

    Uploaded by

    Chris Denver Bancale
    Apidra is an anti-diabetic drug given subcutaneously every 8 hours if blood glucose is over 180. It works by stimulating glucose uptake and inhibiting hepatic glucose production, lowering blood glucose. Apidra is indicated for type 1 diabetes in adults and children and type 2 diabetes in adults. Side effects include hypoglycemia, insulin resistance, lipodystrophy, lipohypertrophy, and local allergic reactions. Nurses monitor patients for signs of hypoglycemia and allergic reactions and assess weight changes requiring insulin dose adjustments.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd

    Drug Study Apidra

    Uploaded by

    Chris Denver Bancale
    1K views1 page
    Apidra is an anti-diabetic drug given subcutaneously every 8 hours if blood glucose is over 180. It works by stimulating glucose uptake and inhibiting hepatic glucose production, lowering blood glucose. Apidra is indicated for type 1 diabetes in adults and children and type 2 diabetes in adults. Side effects include hypoglycemia, insulin resistance, lipodystrophy, lipohypertrophy, and local allergic reactions. Nurses monitor patients for signs of hypoglycemia and allergic reactions and assess weight changes requiring insulin dose adjustments.

    Original Description:

    ICS lets go

    Copyright

    © © All Rights Reserved

    Available Formats

    DOCX, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Apidra is an anti-diabetic drug given subcutaneously every 8 hours if blood glucose is over 180. It works by stimulating glucose uptake and inhibiting hepatic glucose production, lowering blood glucose. Apidra is indicated for type 1 diabetes in adults and children and type 2 diabetes in adults. Side effects include hypoglycemia, insulin resistance, lipodystrophy, lipohypertrophy, and local allergic reactions. Nurses monitor patients for signs of hypoglycemia and allergic reactions and assess weight changes requiring insulin dose adjustments.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd
    Download as docx, pdf, or txt
    1K views1 page

    Drug Study Apidra

    Uploaded by

    Chris Denver Bancale
    Apidra is an anti-diabetic drug given subcutaneously every 8 hours if blood glucose is over 180. It works by stimulating glucose uptake and inhibiting hepatic glucose production, lowering blood glucose. Apidra is indicated for type 1 diabetes in adults and children and type 2 diabetes in adults. Side effects include hypoglycemia, insulin resistance, lipodystrophy, lipohypertrophy, and local allergic reactions. Nurses monitor patients for signs of hypoglycemia and allergic reactions and assess weight changes requiring insulin dose adjustments.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd
    Download as docx, pdf, or txt
    of 1

    Name of Drug Classification Dose/Freq/Route Mechanism of Action Indication Side effect Nursing Implication

    Apidra Anti-Diabetic Give if CBG>180 Insulins lower blood Type 1 diabetes (in Hypoglycemia Assess patient for signs
    glucose by adults and children) Insulin resistance and symptoms of
    4/SC/Q8 stimulating and type 2 diabetes Lipodystrophy hypoglycemia (anxiety;
    peripheral glucose (in adults). Lipohypertrophy restlessness; tingling in
    uptake by skeletal Local allergic rxn hands, feet, lips, or
    muscle and fat, and Hypokalemia tongue; chills; cold
    by inhibiting hepatic sweats; confusion; cool,
    glucose production pale skin; difficulty in
    concentration;
    drowsiness; nightmares
    or trouble sleeping;
    excessive hunger;
    headache; irritability;
    nausea; nervousness;
    tachycardia; tremor;
    weakness; unsteady
    gait)

    Monitor body weight


    periodically. Changes in
    weight may necessitate
    changes in insulin dose

    Assess patient for signs


    of allergic reactions
    (rash, shortness of
    breath, wheezing, rapid
    pulse, sweating, low BP)
    during therapy

    You might also like